Tenth hGH Symposium, Seville, Spain, 23-24 April 1999: Growth hormone releasing substances: Types and their receptors

Hormone Research

Volumn 51, Issue SUPPL. 3, 1999, Pages 1-8

  Smith, Roy G ^a,b   Palyha, Oksana C ^b   Feighner, Scott D ^b   Tan, Carina P ^b   McKee, Karen Kulju ^b   Hreniuk, Donna L ^b   Yang, Lihu ^b   Morriello, Greg ^b   Nargund, Ravi ^b   Patchett, Arthur A ^b   Howard, Andrew D ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Family members; Growth hormone secretagogue receptor; Growth hormone secretagogue receptor ligands; Orphan receptor

Indexed keywords

1 [2 (2 AMINO 2 METHYLPROPIONYLAMINO) 3 (1H INDOL 3 YL)PROPIONYL] 3 BENZYL 3 PIPERIDINECARBOXYLIC ACID ETHYL ESTER; 2 AMINO 2 METHYL N [2,3,4,5 TETRAHYDRO 1 [[2' [[[(METHYLAMINO)CARBONYL]AMINO]METHYL][1,1' BIPHENYL] 4 YL]METHYL] 2 OXO 1H BENZAZEPIN 3 YL]PROPIONAMIDE; GROWTH HORMONE RELEASING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE RECEPTOR; IBUTAMOREN; L 168740; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CONFERENCE PAPER; FISH; GENE LIBRARY; HORMONE RECEPTOR INTERACTION; HORMONE SYNTHESIS; HUMAN; MOLECULAR CLONING; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEQUENCE HOMOLOGY;

EID: 0032697174     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, Newlander K: Design, synthesis, and biological activity of peptides which release growth hormone, in vitro. Endocrinology 1981;108:31-39.
2. Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg W: Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982;218: 585-587.
3. Rivier J, Spiess J, Thorner MO, Vale W: Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 1982;300:276-278.
4. Bowers CY, Momany FA, Reynolds GA, Hong A: On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984;114:1537-1545.
5. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO: Growth hormone (GH)-releasing peptide stimulates GH release in normal man and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 1990;70:975-982.
6. Bowers CY: Xenobioticgrowth hormone secretagogues: growth hormone releasing peptides: in Bercu BB, Walker RF (eds): Xenobiotic Growth Hormone Secretagogues: Growth Hormone Releasing Peptides. New York, Springer, 1996, pp 9-28.
7. Deghenghi R: Growth hormone releasing peptides; in Bercu BB, Walker RF (eds): Growth Hormone Releasing Peptides. New York, Springer, 1996, pp 85-102.
8. McDowell RS, Elias KA, Stanley MS, Burdick DJ, Burnier JP, Chan KS, Fairbrother WJ, Hammonds RG, Ingle GS, Jacobsen NE, Mortensen DL, Rawson TE, Won WB, Clark RG, Somers TC: Growth hormone secretagogues: characterization, efficacy and minimal bioactive conformation. Proc Natl Acad Sci USA 1995;92:11165-11169.
9. Smith RG, Cheng K, Schoen WR, Pong S-S, Hickey GJ, Jacks TM, Butler BS, Chan WW-S, Chaung L-YP, Judith F, Taylor AM, Wyvratt MJ Jr, Fisher MH: A nonpeptidyl growth hormone secretagogue. Science 1993;260:1640-1643.
10. Chapman IM, Hartman ML, Pezzoli SS, Thorner MO: Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults - a clinical research center study. J Clin Endocrinol Metab 1996;81: 2874-2880.
11. Nargund RP, Patchett AA, Bach MA, Murphy MG, Smith RG: Peptidomimetic growth hormone secretagogues - design considerations and therapeutic potential. J Med Chem 1998; 41:3103-3127.
12. Elias KA, Ingle GS, Burnier JP, Hammonds RG, McDowell RS, Rawson TE, Somers TC, Stanley MS, Cronin MJ: In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 1995;136: 5694-5699.
13. Peschke B, Madsen K, Hansen BS, Johansen NL: Aminomethylthiophene-2-carboxylic acids as dipeptide mimetic in new growth hormone secretagogues. Bioorg Med Chem Lett 1997;7:1969-1972.
14. Patchett AA, Nargund RP, Tata JR, Chen MH, Barakat KJ, Johnston DBR, Cheng K, Chan WW-S, Butler BS, Hickey GJ, Jacks TM, Scleim K, Pong S-S, Chaung L-YP, Chen HY, Frazier E, Leung KH, Chui S-HL, Smith RG: The design and biological activities of L-163,191 (MK-0677): a potent orally active growth hormone secretagogue. Proc Natl Acad Sci USA 1995;92:7001-7005.
15. Chapman IM, Bach MA, Van Cauter E, Farmer M, Krupa DA, Taylor AM, Schilling LM, Cole KY, Skiles EH, Pezzoli SS, Hartman ML, Veldhuis JD, Gormley GJ, Thorner MO: Stimulation of the growth hormone (GH)-insulin-like growth factor-I axis by daily oral administration of a GH secretagogue (MK-0677) in healthy elderly subjects. J Clin Endocrinol Metab 1996;81:4249-4257.
16. DeVita RJ, Bochis R, Frontier AJ, Kotliar A, Fisher MH, Schoen WR, Wyvratt MJ, Cheng K, Chan WW-S, Butler B, Jacks TM, Hickey GJ, Schleim KD, Leung L, Chen Z, Chiu LS-H, Feeney WP, Cunningham PK, Smith RG: A potent, orally bioavailablc benzazepinone growth hormone secretagogue. J Med Chem 1998;41:1716-1728.
17. Yang L, Morriello G, Patchett AA, Leung K, Jacks T, Cheng K, Schleim DD, Fenney W. Chan W, Chiu S-HL, Smith RG: 1-[2(R)-(2-amino-2-methylpropionyl-amino)-3-(1H-indol-3-yl)propionyl]-3- benzylpiperidine-3-(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue. J Med Chem 1998;41:2439-2441.
18. Dean DC, Nargund RP, Pong S-S, Chaung L-YP, Griffin PR, Melillo DG, Ellsworth RL, Van der Ploeg LHT, Patchett AA, Smith RG: Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor. J Med Chem 1996;39:1767-1770.
19. Pong S-S, Chaung L-Y, Dean DC, Nargund RP, Patchett AA, Smith RG: Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 1996;10: 57-61.
20. Smith RG, Pong S-S, Hickey GJ, Jacks TM, Cheng K, Leonard RJ, Cohen CJ, Arena JP, Chang CH, Drisko JE, Wyvratt MJ Jr, Fisher MH, Nargund RP, Patchett AA: Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog Horm Res 1996;51:261-286.
21. Bresson-Bepoldin L, Dufy-Barbe L: GHRP-6 induces a biphasic calcium response in rat pituitary somatotrophs. Cell Calcium 1994;15: 247-258.
22. Herrington J, Hille B: Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotrophs by two mechanisms. Endocrinology 1994;135:1100-1108.
23. Adams EF, Petersen B, Lei T, Buchfelder M, Fahlbusch R: The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors. Biochem Biophys Res Comm 1995;208:555-561.
24. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Díaz C, Chou M, Liu KK, McKee KK, Pong S-S, Chaung L-YP, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund RP, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LHT: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:974-977.
25. McKee KK, Palyha OC, Feighner SD, Hreniuk DL, Tan C, Smith RG, Van der Ploeg LHT, Howard AD: Molecular analysis of growth hormone secretagogue receptors (GHS-Rs): cloning of rat pituitary and hypothalamic GHS-R type 1a cDNAs. Mol Endocrinol 1997;11:415-423.
26. Feighner SD, Howard AD, Prendergast K, Palyha OC, Hreniuk DL, Nargund RP, Underwood D, Tata JR, Dean DC, Tan C, McKee KK, Woods JW, Patchett AA, Smith RG, Van der Ploeg LHT: Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and non-peptide secretagogues. Mol Endocrinol 1998;12:137-145.
27. Guan X-M, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJS, Smith RG, Van der Ploeg LHT, Howard AD: Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 1997;48:23-29.
28. Leng G, Bailey ART, Dickson SL, Smith RG: Electrophysiological studies of the arcuate nucleus: central actions of growth-hormone secretagogues; in Bercu BB, Walker RF (eds): Electrophysiological Studies of the Arcuate Nucleus: Central Actions of Growth-Hormone Secretagogues. New York, Marcel Dekker, 1997, pp 173-186.
29. Bailey ART, Smith RG, Leng G: The non-peptide growth hormone secretagogue, MK-0677, activates hypothalamic neurones in vivo. J Neuroendocrinol 1998;10:111-118.
30. Dickson SL, Luckman SD: Induction of c-fos messenger ribonucleic acid in neuropeptide-Y and growth hormone (GH)-releasing factor neurones in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997; 138:771-777.
31. Bennett PA, Thomas GB, Howard AD, Feighner SD, Van der Ploeg LHT, Smith RG, Robinson ICAF: Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 1997;138:4552-4557.
32. Tannenbaum GS, Lapointe M, Beaudet A, Howard AD: Expression of GH secretagogue-receptors by GH-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 1998;139:4420-4423.
33. Dickson SL, Doutrelant-Viltart O, Dyball REJ, Leng G: Retrogradely labelled neurosecretory neurones of the rat hypothalamic arcuate nucleus express fos protein following systemic injection of growth hormone (GH)-releasing peptide. J Endocr 1996;151:323-331.
34. Honda K, Bailey ART, Bull PM, MacDonald LP, Dickson SL, Leng G: An electrophysiological and morphological investigation of the projections of growth hormone-releasing peptide-6-responsive neurons in the rat arcuate nucleus to the median eminence and to the paraventricular nucleus. Neuroscience 1999;90:875-883.
35. Zheng H, Bailey ART, Jiang M-H, Honda K, Chen HY, Trumbauer ME, Van der Ploeg LHT, Schaeffer JM, Leng G, Smith RG: Somatostatin receptor subtype-2 knockout mice are refractory to growth hormone negative feedback on arcuate neurons. Mol Endocrinol 1997;11:1709-1717.
36. McDonald JK, Lumpkin MD, Samson WK, McCann SM: Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc Natl Acad Sci USA 1985;82:561-564.
37. Chabot G-J, Enjalbert A, Pelletier G, Dubois PM, Morel G: Evidence for a direct action of neuropeptide Y in the rat pituitary gland. Neuroendocrinology 1998;47:511-517.
38. Dickson SL, Leng G, Robinson ICAF: Systemic administration of growth hormone-releasing peptide (GHRP-6) activates hypothalamic arcuate neurones. Neuroscience 1993;53: 303-306.
39. Chapman IM, Pescovitz OH, Murphy G, Treep T, Cerchio CA, Krupa D, Gertz B, Polvino WJ, Skiles EH, Pezzoli SS, Thorner MO: Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/IGF-1 axis in selected GH-deficient adults. J Clin Endocrinol Metab 1997;82: 3455-3463.
40. Murphy MG, Plunkett LM, Gertz BJ, He W, Wittreich J, Polvino WM, Clemmons DR: MK-0677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab 1998;83:320-325.
41. Svensson J, Lönn L, Jansson J-O, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Bosæus I, Sjöström L, Bengtsson B-Å: Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab 1998;83:362-369.
42. Copinschi G, Leproult R, Van Onderbergen A, Gaufriez A, Cole KY, Schilling LM, Mendel CM, De Lepeleire I, Bolognese JA, Van Cauter EV: Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology 1997;66:278-286.
43. 4) levels in beagles. J Endocrinol 1994;143:399-406.
44. Smith RG, Van der Ploeg LHT, Cheng K, Hickey GJ, Wyvratt JMJ, Fisher MH, Nargund RP, Patched AA: Peptidomimetic regulation of growth hormone (GH) secretion. Endocr Rev 1997;18:621-645.
45. Muccioli G, Ghè C, Ghigo MC, Arvat E, Papotti M, Boghen MF, Nilsson M, Deghenghi R, Ong H, Ghigo E: GHRP receptors in pituitary, central nervous system and peripheral human tissues. J Endocrinol Invest 1997;20(suppl 4): 52.
46. De Gennaro Colonna V, Rossoni G, Bernareggi M, Muller EE, Berti F: Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin. Eur J Pharmacol 1997; 334:201-207.
47. McKee KK, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk DL, Smith RG, Howard AD, Van der Ploeg LHT: Cloning and characterization of two human G protein-coupled receptor genes related to the growth hormone secretagogue and neurotensin receptors. Genomics 1997;46:426-434.
48. Tan CP, McKee KK, Liu Q, Palyha OC, Feighner SD, Hreniuk DL, Smith RG, Howard AD: Cloning and characterization of a human and murine T-cell orphan G protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. Genomics 1998;52:223-229.
49. Hinegardner R: Evolution of cellular DNA content in teleost fishes. Am Naturalist 1968; 102(928):517-523.
50. Brenner S, Elgar G, Sandford R, Macrae A, Venkatesh B, Aparicio S: Characterisation of the pufferfish (Fugu) genome as a compact vertebrate genome. Nature 1993;366:265-268.
51. Macrae AD, Brenner S: Analysis of the dopamine receptor family in the compact genome of the pufferfish Fugu rubripes. Genomics 1995; 25(2);436-446.
52. Macrae AD, Brenner S: One armed PCR (OA-PCR): amplification of genomic DNA from a single primer domain. Genomics 1994;24(1): 176-178.
53. Murphy D, Si-Hoe S-L, Brenner S, Venkatesh B: Something fishy in the rat brain: molecular genetics of the hypothalamo-neurohypophysial system. BioEssays 1998;20:741-749.
54. Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong S-S, Austin CP, Figuereoa D, MacNeil D, Cascieri MA, Nargund R, Bakshi R, Abramovitz M, Stocco R, Kargman S, O'Neill G, Van Der Ploeg LHT, Evans J, Patchett AA, Smith RG, Howard AD: Receptor for motilin identified in the human gastrointestinal system. Science 1999;284:2184-2188.
55. Palyha OC, Feighner SD, Tan CP, McKee KK, Hreniuk DL, Gao Y-D, Nargund R, Patchett AA, Howard AD, Smith RG: Ligand activation domain of human orphan growth hormone secretagogue receptor (GHS-R) conserved from puffer fish to humans. Mol Endocrinol (in press).